xpovio comprimé
forus therapeutics inc. - sélinexor - comprimé - 20mg - sélinexor 20mg
tecvayli
janssen-cilag international n.v. - teclistamab - le myélome multiple - agents antinéoplasiques - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.
darzalex 20 mg/ml concentrat solució perfussió 1 vial 20 ml
darzalex 20 mg/ml concentrat solució perfussió 1 vial 5 ml